Skip to main content

Remote Job Finders (RJF)

Lilly’s Foundayo posts ‘outstanding’ diabetes data, possibly easing FDA safety concerns

Right after the FDA flagged safety concerns for Eli Lilly’s newly approved obesity pill, the pharma posted diabetes data demonstrating a clean safety profile and revealed plans to seek approval in the indication.

Revolution doubles stock offering target to $2B following pancreatic cancer win

After Revolution Medicines’ drug candidate doubled survival in a Phase 3 pancreatic cancer study, the biotech is hoping to attract more investor money, with new plans for a $2 billion stock and debt offering.
Scroll to top